Prices delayed by at least 15 minutes | Print
N4 Pharma PLC (N4P)
ORD 0.4POpen
0.675p
Previous close
0.675p
Trade high
0.75p
Volume
1,668,891
Year high
2.30p
Year low
0.60p
Dividend yield
-
Market capitalisation
£1.75 mn
P/E ratio
-
ISIN
GB00BYW8QM32
This share can be held in a Dealing accountISALifetime ISAJISASIPPand can be used with Dividend reinvestment
Share price
Company profile
N4 Pharma PLC is the holding company for N4 UK. N4 UK is a specialist pharmaceutical company engaged in the development of nanoparticle silica delivery systems to improve the cellular delivery and potency of cancer treatments and vaccines. The company operated in one business segment, that of the development and commercialisation of medicines via its delivery system called Nuvec.
News
Recent trades
Date | Time | Price | Quantity | Value (£) |
---|---|---|---|---|
28/03/2024 | 04:20:27 | 0.7 | 1,428 | 10.00 |
28/03/2024 | 04:20:13 | 0.64 | 344,883 | 2,207.25 |
28/03/2024 | 04:14:48 | 0.64 | 160,623 | 1,027.99 |
28/03/2024 | 03:46:57 | 0.6 | 1,000 | 6.00 |
28/03/2024 | 03:40:24 | 0.6 | 700 | 4.20 |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2024 AJ Bell. All rights reserved.